These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27835665)

  • 1. Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β Signaling.
    Kim J; Kim J; Lee SH; Kepreotis SV; Yoo J; Chun JS; Hajjar RJ; Jeong D; Park WJ
    PLoS One; 2016; 11(11):e0166480. PubMed ID: 27835665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
    Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
    J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.
    Sun Z; Schriewer J; Tang M; Marlin J; Taylor F; Shohet RV; Konorev EA
    J Mol Cell Cardiol; 2016 Jan; 90():129-38. PubMed ID: 26686989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.
    Uchinaka A; Kawaguchi N; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N
    Cardiovasc Res; 2013 Jul; 99(1):102-10. PubMed ID: 23615564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
    Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
    Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CCR2-binding features in Cytl1 by a CCL2-like chemokine model.
    Tomczak A; Pisabarro MT
    Proteins; 2011 Apr; 79(4):1277-92. PubMed ID: 21322034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.
    Ghosh AK; Nagpal V; Covington JW; Michaels MA; Vaughan DE
    Cell Signal; 2012 May; 24(5):1031-6. PubMed ID: 22245495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.
    Saxena A; Shinde AV; Haque Z; Wu YJ; Chen W; Su Y; Frangogiannis NG
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):223-31. PubMed ID: 26542797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.
    Chen YH; Wang Q; Li CY; Hou JW; Chen XM; Zhou Q; Chen J; Wang YP; Li YG
    J Mol Cell Cardiol; 2017 Apr; 105():1-11. PubMed ID: 28214509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased MCP-1/CCR2 axis-mediated chemotactic effect of conjunctival fibroblasts after transdifferentiation into myofibroblasts.
    Tsutsumi-Kuroda U; Inoue T; Futakuchi A; Shobayashi K; Takahashi E; Kojima S; Inoue-Mochita M; Fujimoto T; Tanihara H
    Exp Eye Res; 2018 May; 170():76-80. PubMed ID: 29458061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fra-2 mediates oxygen-sensitive induction of transforming growth factor beta in cardiac fibroblasts.
    Roy S; Khanna S; Azad A; Schnitt R; He G; Weigert C; Ichijo H; Sen CK
    Cardiovasc Res; 2010 Sep; 87(4):647-55. PubMed ID: 20427335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation.
    Woods LT; Camden JM; El-Sayed FG; Khalafalla MG; Petris MJ; Erb L; Weisman GA
    PLoS One; 2015; 10(5):e0123641. PubMed ID: 25955532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.
    Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS
    J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model.
    Chen YH; Liang CM; Chen CL; Chen JT; Chang YH; Lu DW; Chien KH; Tai MC
    Acta Ophthalmol; 2013 Nov; 91(7):e506-15. PubMed ID: 23764119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of BTK ameliorates the pathological cardiac fibrosis and dysfunction.
    Wang B; Tan Y; Zhou W; Yang J; Jiang Y; Liu X; Zhan Z
    Matrix Biol; 2022 Sep; 112():171-189. PubMed ID: 36031013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.
    Ishida W; Mori Y; Lakos G; Sun L; Shan F; Bowes S; Josiah S; Lee WC; Singh J; Ling LE; Varga J
    J Invest Dermatol; 2006 Aug; 126(8):1733-44. PubMed ID: 16741519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways.
    Cheng X; Wang L; Wen X; Gao L; Li G; Chang G; Qin S; Zhang D
    EBioMedicine; 2021 May; 67():103370. PubMed ID: 33971401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.